These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 31242496)
1. Comparison of the Upgrading Rates of International Society of Urological Pathology Grades and Tumor Laterality in Patients Undergoing Standard 12-Core Prostate Biopsy versus Fusion Prostate Biopsy for Prostate Cancer. Demirtaş A; Sönmez G; Tombul ŞT; Demirtaş T; Akgün H Urol Int; 2019; 103(3):256-261. PubMed ID: 31242496 [TBL] [Abstract][Full Text] [Related]
2. Risk of Upgrading from Prostate Biopsy to Radical Prostatectomy Pathology-Does Saturation Biopsy of Index Lesion during Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Help? Calio BP; Sidana A; Sugano D; Gaur S; Maruf M; Jain AL; Merino MJ; Choyke PL; Wood BJ; Pinto PA; Turkbey B J Urol; 2018 Apr; 199(4):976-982. PubMed ID: 29154904 [TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging target fusion biopsy vs. transrectal ultrasound-guided biopsy - A comparative study of ISUP score upgrading risk in the final radical prostatectomy specimen. Guimarães T; Gil M; Medeiros M; Andrade V; Guerra J; Pinheiro H; Fernandes F; Pina J; Lopes Dias J; Campos Pinheiro L Arch Ital Urol Androl; 2022 Sep; 94(3):278-284. PubMed ID: 36165470 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance and risk factors of International Society of Urological Pathology (ISUP) grade upgrading in prostate cancer patients undergoing robot-assisted radical prostatectomy. Takeshima Y; Yamada Y; Teshima T; Fujimura T; Kakutani S; Hakozaki Y; Kimura N; Akiyama Y; Sato Y; Kawai T; Yamada D; Kume H BMC Cancer; 2021 May; 21(1):501. PubMed ID: 33947348 [TBL] [Abstract][Full Text] [Related]
6. Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling. Luzzago S; Petralia G; Maresca D; Sabatini I; Cordima G; Brescia A; Verweij F; Garelli G; Mistretta FA; Cioffi A; Pricolo P; Alessi S; Ferro M; Matei DV; Renne G; de Cobelli O; Musi G Urol Oncol; 2020 Dec; 38(12):929.e11-929.e19. PubMed ID: 32600928 [TBL] [Abstract][Full Text] [Related]
7. Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study. Zattoni F; Marra G; Martini A; Kasivisvanathan V; Grummet J; Harkin T; Ploussard G; Olivier J; Chiu PK; Valerio M; Marquis A; Gontero P; Guo H; Zhuang J; Frydenberg M; Moon D; Morlacco A; Kretschmer A; Barletta F; Heidegger I; Tilki D; van den Bergh R; Dal Moro F; Briganti A; Montorsi F; Novara G; Gandaglia G; Eur Urol Focus; 2023 Jul; 9(4):621-628. PubMed ID: 36746729 [TBL] [Abstract][Full Text] [Related]
8. A multicentric study on accurate grading of prostate cancer with systematic and MRI/US fusion targeted biopsies: comparison with final histopathology after radical prostatectomy. Diamand R; Oderda M; Al Hajj Obeid W; Albisinni S; Van Velthoven R; Fasolis G; Simone G; Ferriero M; Roche JB; Piechaud T; Pastore A; Carbone A; Fiard G; Descotes JL; Marra G; Gontero P; Altobelli E; Papalia R; Kumar P; Eldred-Evans D; Giacobbe A; Muto G; Lacetera V; Beatrici V; Roumeguere T; Peltier A World J Urol; 2019 Oct; 37(10):2109-2117. PubMed ID: 30652213 [TBL] [Abstract][Full Text] [Related]
9. Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1-2 prostate cancer at MRI-targeted biopsy: a multicenter analysis. Kesch C; Pantea V; Soeterik T; Marquis A; la Bombarda G; Morlacco A; Barletta F; Radtke JP; Darr C; Preisser F; Zattoni F; Marra G; van den Bergh RCN; Hadaschik B; Gandaglia G; World J Urol; 2023 Feb; 41(2):427-434. PubMed ID: 36534151 [TBL] [Abstract][Full Text] [Related]
10. Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer. Choi YH; Yu JW; Kang MY; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG World J Urol; 2019 Oct; 37(10):2129-2135. PubMed ID: 30603783 [TBL] [Abstract][Full Text] [Related]
11. Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit. Radtke JP; Takhar M; Bonekamp D; Kesch C; Erho N; du Plessis M; Buerki C; Ong K; Davicioni E; Hohenfellner M; Hadaschik BA Eur Urol Focus; 2018 Jul; 4(4):540-546. PubMed ID: 28753844 [TBL] [Abstract][Full Text] [Related]
12. Should Hypoechoic Lesions on Transrectal Ultrasound Be Sampled During Magnetic Resonance Imaging-targeted Prostate Biopsy? Shakir NA; Siddiqui MM; George AK; Kongnyuy M; Ho R; Fascelli M; Merino MJ; Turkbey B; Choyke PL; Wood BJ; Pinto PA Urology; 2017 Jul; 105():113-117. PubMed ID: 27864107 [TBL] [Abstract][Full Text] [Related]
13. A Single Center Evaluation of the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging against Transperineal Prostate Mapping Biopsy: An Analysis of Men with Benign Histology and Insignificant Cancer following Transrectal Ultrasound Biopsy. Pal RP; Ahmad R; Trecartan S; Voss J; Ahmed S; Bazo A; Lloyd J; Walton TJ J Urol; 2018 Aug; 200(2):302-308. PubMed ID: 29477717 [TBL] [Abstract][Full Text] [Related]
14. Can Extraprostatic Extension Be Predicted by Tumor-Capsule Contact Length in Prostate Cancer? Relationship With International Society of Urological Pathology Grade Groups. Bakir B; Onay A; Vural M; Armutlu A; Yıldız SÖ; Esen T AJR Am J Roentgenol; 2020 Mar; 214(3):588-596. PubMed ID: 31670596 [No Abstract] [Full Text] [Related]
15. Magnetic Resonance Imaging-Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance. Tran GN; Leapman MS; Nguyen HG; Cowan JE; Shinohara K; Westphalen AC; Carroll PR Eur Urol; 2017 Aug; 72(2):275-281. PubMed ID: 27595378 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Gleason upgrading rates in transrectal ultrasound systematic random biopsies versus US-MRI fusion biopsies for prostate cancer. Kayano PP; Carneiro A; Castilho TML; Sivaraman A; Claros OR; Baroni RH; Garcia RG; Mariotti GC; Smaletz O; Filippi RZ; Lemos GC Int Braz J Urol; 2018; 44(6):1106-1113. PubMed ID: 30325600 [TBL] [Abstract][Full Text] [Related]
17. Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes? Deniffel D; Salinas E; Ientilucci M; Evans AJ; Fleshner N; Ghai S; Hamilton R; Roberts A; Toi A; van der Kwast T; Zlotta A; Finelli A; Haider MA; Perlis N J Urol; 2020 Dec; 204(6):1187-1194. PubMed ID: 32496160 [TBL] [Abstract][Full Text] [Related]
18. A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings. Luzzago S; de Cobelli O; Cozzi G; Peveri G; Bagnardi V; Catellani M; Di Trapani E; Mistretta FA; Pricolo P; Conti A; Alessi S; Marvaso G; Ferro M; Matei DV; Renne G; Jereczek-Fossa BA; Petralia G; Musi G BJU Int; 2020 Jul; 126(1):104-113. PubMed ID: 32150328 [TBL] [Abstract][Full Text] [Related]
19. Optimizing Spatial Biopsy Sampling for the Detection of Prostate Cancer. Raman AG; Sarma KV; Raman SS; Priester AM; Mirak SA; Riskin-Jones HH; Dhinagar N; Speier W; Felker E; Sisk AE; Lu D; Kinnaird A; Reiter RE; Marks LS; Arnold CW J Urol; 2021 Sep; 206(3):595-603. PubMed ID: 33908801 [TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients. Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]